Home > Healthcare & Medical Devices > Genetic Testing Market

Genetic Testing Market Size By Test Type (Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing), By Application (Cancer, Genetic Disease, Cardiovascular Disease), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI2490
  • Published Date: Mar 2021
  • Report Format: PDF

Industry trends

Genetic Testing Market size surpassed USD 14.8 billion in 2020 and is poised to grow at over 11.6% CAGR between 2021 and 2027. Introduction of novel technologies as well as techniques for genetic testing with increased accuracy and efficiency will serve to be a high impact rendering factor for the market growth.
 

Genetic Testing Market

Get more details on this report - Request Free Sample PDF
 

The availability of efficient and highly sensitive methods of DNA sequencing for prenatal genetic testing further offer new approaches for initial screening test during new pregnancies. These methods allow detection of small amounts of fetal DNA that circulates naturally in the mother's blood during pregnancy. Moreover, development of NGS, a rapidly evolving technology that enables sequencing of a whole genome or part of a genome and rapid extraction of genetic information from biological materials will fuel the adoption of genetic tests in near future.
 

Increasing demand for diagnostic testing across the globe

The diagnostic testing segment is estimated to witness around 11% growth rate through 2027, owing to surging incidence of genetic and other chronic disorders. According to the data published on WHO, rising prevalence of inherited diseases including sickle cell anaemia, cystic fibrosis and haemophilia will fuel the genetic testing market demand. In addition, early disease diagnosis further allows patients to undergo therapeutic treatment at an early stage that minimizes the severity of disease leading to reduced mortality rate.
 

Growing number of cancer cases caused by genetic mutation

Genetic Testing Market Size

Get more details on this report - Request Free Sample PDF
 

Cancer segment value in the genetic testing market was over USD 7.7 billion in 2020. Cancer, globally, is the 2nd leading cause of death, and nearly 70% of deaths from cancer occur in low- and middle-income countries that raises the demand for genetic testing. Genetic testing helps to estimate the chances of developing cancer throughout an individual’s lifetime by examining for specific changes in proteins, chromosomes, and genes; resulting in reduced morbidity, less expensive treatment, and greater probability of surviving.
 

Presence of large number of industry players in North America region will accelerate the market demand for genetic testing

North America Genetic Testing Market

Get more details on this report - Request Free Sample PDF
 

North America dominated the global genetic testing market, accounting over USD 8.5 billion revenue in 2020. This higher regional market size is attributed to rising number of cancer cases and other chronic ailments as well as rapidly growing elderly population base.
 

Presence of prominent market players operational in genetic testing along with favourable regulatory scenario further proves advantageous for the market expansion. In addition, growing adoption of new technologies, rising patient awareness for early disease diagnosis and surging incidence of genetic diseases will boost the market demand.
 

Various growth strategies undertaken by prominent industry players

Some of the major companies operating in the market include 23andMe, Inc., Abbott Laboratories, Ambry Genetics (Konica Minolta), BGI, Biocartis Group NV, Bio-Helix Co., Ltd., bioMérieux SA, Blueprint Genetics, Cepheid (Danaher Corporation), and Eurofins Scientific. These players are undertaking several growth strategies to sustain the market position.
 

The genetic testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Test Type

  • Predictive testing
  • Carrier testing
  • Prenatal and newborn testing
  • Diagnostic testing
  • Pharmacogenomic testing
  • Nutrigenomic testing
  • Others

Market, By Application

  • Cancer
  • Genetic diseases
  • Cardiovascular diseases
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The market size of genetic testing surpassed USD 14.8 billion in 2020 and is poised to grow at over 11.6% CAGR between 2021 and 2027.

The diagnostic testing segment is estimated to witness around 11% growth rate through 2027, owing to surging incidence of genetic and other chronic disorders.

The industry revenue from cancer segment had reached USD 7.7 billion during 2020 and will expand significantly through 2027, due to the need to early diagnosis and avoiding postponement of required care.

North America dominated the global market, accounting over USD 8.5 billion revenue in 2020, attributed to rising number of cancer cases and other chronic ailments as well as rapidly growing elderly population base.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2020
  • Companies covered: 21
  • Tables & Figures: 145
  • Countries covered: 19
  • Pages: 200

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount